Navigation Links
The potent anti-leukemia activity of Berbamine

Chronic myeloid leukemia (CML) is a pluripotent hematopoietic stem cell disorder characterized by accumulation of mature and immature granulocytes in peripheral blood and bone marrow due to uncontrolled growth // and resistance to apoptosis. The dysregulated activity of the bcr/abl oncoprotein tyrosine kinase, which is encoded by the bcr?abl fusion gene, has been shown to be responsible for the malignant phenotypes.

Gleevec, which is an inhibitor of the bcr/abl tyrosine kinase, has been a remarkable success for the treatment of CML. However, a significant proportion of patients chronically treated with Gleevec develop resistance. Thus, new approaches that override the resistance are crucial to the development of curative therapies for CML.

A recent study, to be published in Leukemia Research (available online 14 July 2005) describes the anti-leukemia activity of a natural small molecular compound, berbamine from plant Berberis amurensis that can selectively induce cell death of both Gleevec-sensitive and -resistant Ph+ CML cells.

Importantly, the results in this study show that berbamine is also active against Gleevec-resistant leukemia cells. It is of interest to note that berbamine down-regulates p210 bcr/abl oncoprotein of Ph+ leukemia cells, suggesting that this compound have different anti-leukemia mechanism from that of Gleevec.

The results indicate that up to 76% of leukemia cells were apoptotic cells after treatment with berbamine at concentration of 16 ì g/ml for 48 h, suggesting that the growth inhibition of berbamine for leukemia cells is caused by apoptosis of leukemia cells. Results also suggest that berbamine-induced apoptosis is mediated via caspase-3-dependent pathway.

Another important feature of berbamine is the very desirable safety that is not often seen in conventional chemotherapeutic agents. In addition, berbamine is widely used to improve normal hematopoiesis and immune function of c
'"/>




Page: 1 2

Related medicine news :

1. Hepatitis E virus made impotent
2. Unwed mothers find it difficult to attract potential life partner
3. Unpasteurised juices found to be potential health hazards
4. The many facets of milk and its health potential
5. Artificial sweetener, Aspartame, may be the potential cause of lymphoma, leukaemia
6. Alcohol a potential carcinogen: knocking on the door: pay heed!
7. A potent causative agent of dental flourosis: Fluoride
8. Quebec arming itself to combat a potential influenza pandemic
9. Smoking Is a Vital Cause among Impotent Men
10. Pluripotent ESC, To Serve As an Effective Therapy for Many Diseases
11. Estrogen also a potential neurotransmitter
Post Your Comments:
(Date:7/9/2008)...l Research Warranted on Impact of Medicare Moderni...enges; Data Shows Possibility of,Longer Wait Times...y 9 /PRNewswire-USNewswire/ -- According to a new ...nal of the American Medical,Association (JAMA), ca...r,access to quality cancer care following the pass...
(Date:7/9/2008)...pneumococcal vaccine (Prevenar) was introduced in ... years later, the experiences have been published ...g decline in serious pneumococcal infections among...that can cause serious illnesses in some young chi...nia. Most of those who become ill are previously h...
(Date:7/9/2008)...c outcome after lumpectomy linked to depression, f...HealthDay News) -- A third of women who opt for br...n asymmetry between their breasts that greatly aff... Women whose affected breast looked noticeably dif...their cancer returning and to have symptoms of dep...
(Date:7/9/2008)...ed MCO Pharmacy Directors Will Move Razadyne and R...dyne is Launched, According to a New ...ass., July 9 /PRNewswire/ -- Decision Resources, o...rms for pharmaceutical and,healthcare issues, find...rtho McNeil,s Razadyne (galantamine) in December 2...
Breaking Medicine News(10 mins):Health News:Global Access Project (GAP) Study Examining Patients' Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA) 2Health News:Vaccinated infants well-protected against severe pneumococcal infection in Norway 2Health News:Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 3
...ost half of all newly-diagnosed lung cancer cases.... do not disappear as soon as people quit, as it ta...en found that smoking causes genetic damage in the... from becoming cancerous. Researchers from the Uni...
...ched the first two head-to-head clinical trials th...x (alendronate) once weekly 70mg and Actonel (rise...th bisphosphonates indicated for the treatment of ...keted by Aventis and Procter & Gamble through the ...
...n children, which lead to chronic health problems ...ediatricians in the treatment of obesity in childr... kids are getting. A recent study has shown that c...aking them fall short of the American National gui...
...on people go to the Emergency Room(ER) with chest ...t receive an ECG and other standard tests to deter...rious heart problems. However, ECGs can be complet...ce. ECGs are also sometimes unable to identify uns...
Other Medicine News:
(Date:7/8/2008)... SAN MATEO, Calif., July 8 /- After m...ecommended that all new diabetes drugs should,unde... US cardiologists and,65% of US endocrinologists a...etail Inc., a leader in cardiovascular and metabol...mapping solutions to the Global Life,Sciences Indu...
(Date:7/8/2008)... 96-week comparative study of Clevudine versus ...atients with chronic hepatitis B, PRINCETON, N.J....onal,Agency for Research on AIDS and Viral Hepatit...asdaq: VRUS ) and Gilead Sciences, Inc. (Nasdaq: ...y of clevudine and Viread(R),(tenofovir disoproxil...
(Date:7/7/2008)...olecular Biometrics presents scientific evidence s... metabolomics platform at major international ...Spain and CHESTER, N.J., July 7 /- Mo...mics company developing novel,clinical tools for a...ately,characterize biologic function in health and...
(Date:7/7/2008)... New Study Suggests Kiwifruit is Top Performe...t all fruits are created equal when,it comes to th...mong the,highest in bioavailability compared to ot...t small-scale study published in the Journal of th...clude vitamins and phytochemicals called flavonoid...
Breaking Medicine Technology:AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 3Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 4Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Kiwifruit: Antioxidant Power in Quantity and Quality 2Childrens Hospital Boston Ranked Number One in New England 20636 1Childrens Hospital Boston Ranked Number One in New England 20636 2Childrens Hospital Boston Ranked Number One in New England 20636 3A common aquatic animals genome can capture foreign DNA 3478 1A common aquatic animals genome can capture foreign DNA 3478 2Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 1Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 2Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 3Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 4Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 5U S News 2008 Best Hospitals Issue Again Ranks Packard Childrens as One of Nations Best 20633 1U S News 2008 Best Hospitals Issue Again Ranks Packard Childrens as One of Nations Best 20633 2
...OLIS, France, May 11, 2007 /PRNewswire-FirstCall/ ...date on the phase 2a,study for NCX 1000, which is ...Pharma Inc. A preliminary analysis of 11 patients...ension confirmed,the safety profile of NCX 1000 bu...port the continuation of this clinical trial. As a...
...tional vaccine could offer protection,for infants ...ococcal disease , , TORONTO, Canada, May 11...results from a,Phase II vaccine clinical study pre...es’ (PAS) Annual Meeting in,Toronto, Canada....-MenCY-TT vaccine holds potential to protect infan...
Other Medicine Technology:NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 2GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 3GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 4GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 5
Full Handle Laseredge Stab Blade Knife, 22.5 blade. Blade tip dimension: 10.7 mm x 1.8 mm x 4.2 mm.
19 Gauge. Reusable. Block of 4 each.
18 gauge curved. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation.
Set consist of two 23 gauge, stainless steel probes with blunt tips. Probes are 18 cm (7.0 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attached onto the
Medicine Products: